Register now to celebrate the 10th anniversary of the Professional Symposium, a day of fun interactive learning suitable for all optometrists, ophthalmic nurses, technicians, GP’s and ophthalmologists to attend.
Uncertainty is intrinsic to glaucoma care rather than a failure of expertise. Reflection on cognitive bias, evolving evidence, and patient-centred reasoning reinforces the role of humility and adaptability in clinical decision-making.
Topics presented synthesise the day’s themes, encouraging clinicians to tolerate ambiguity while remaining vigilant for change. Cultivating disciplined judgement rather than reflexive intervention is presented as central to high-quality glaucoma care.
This is a day of fast paced, interactive learning so be ready to enjoy good barista coffee, birthday cake, gift bags, and food in good company. Read the programme and abstracts – 2026 The Grey Zones Programme
Join us on Sunday 2nd August 2026, Hunua Room, Aotea Centre, Auckland, with FREE parking or online.
Optometry Australia has accredited this programme with 6.5T (6i) CPD.
ODOB – has accredited this programme with 6.16 points (.33 ethical). Certificates for those attending will be issued at the end of the day.
The Grey Zones of Glaucoma: Uncertainty, judgement, and decision-making in everyday practice.
We are thrilled to announce our keynote speaker, Professor Keith Martin, MA BM BCh DM MRCP FRCOphth, FRANZCO FARVO ALCM. Professor Keith Martin is CERA Managing Director, Head of Glaucoma Research, a clinician scientist ophthalmologist and Head of Ophthalmology at the University of Melbourne.
Glaucoma care is entering a period of rapid technological and conceptual change, driven by advances in imaging, artificial intelligence–based analytics, home monitoring, minimally invasive surgical techniques, and novel therapeutic targets. These developments promise earlier detection, more individualised risk stratification, and refined longitudinal surveillance. Yet they also introduce new forms of uncertainty, as clinicians confront expanding data streams, evolving algorithms, and clinical scenarios not yet fully addressed by guidelines or trial evidence.
This keynote examines how emerging tools may reshape diagnosis and management across the disease spectrum, from pre-perimetric glaucoma to advanced disease. Topics include AI-assisted optic nerve assessment, continuous or home intraocular pressure monitoring, remote perimetry, and structural progression analysis at unprecedented resolution. The session explores how these innovations may recalibrate traditional concepts such as target pressure, progression thresholds, and treatment timing, while highlighting the importance of rigorous validation and thoughtful integration into real-world practice.
The address concludes by considering the professional and ethical responsibilities that accompany technological progress. Issues of algorithmic transparency, medico-legal accountability, health-equity implications, and clinician over-reliance on automated systems are critically examined. Rather than presenting innovation as a solution to uncertainty, the keynote argues that the next era of glaucoma care will demand even sharper clinical judgement, combining new tools with disciplined scepticism, patient-centred decision-making, and an enduring willingness to navigate the grey zones with clarity and humility.
“Great programme, as always. Well paced day, variety of speakers”
“A great mix of basic complex and case studies”
“Lots of practical tips, engaging presentations, stimulating”
“I am an orthoptist working as a technician. The day was pitched at a great level for the work I do. I liked the balance of talks and cases”
“It was really relevant. The length of the presentations kept my attention and you offered it online! Fabulous!”
Register now for EARLY BIRD pricing only available until mid-June.